Submit your nominations for the Fierce CRO Awards

fecal transplantation

Concepts of medical examination and study of intestine microflora
Biotech

MaaT's phase 3 GvHD trial hits goal, teeing up microbiome filing

The phase 3 graft-versus-host disease trial hit its primary endpoint, positioning MaaT to seek approval of the microbiome therapy in mid-2025.
Nick Paul Taylor Jan 9, 2025 5:18am
FDA

FDA drops resistance to fecal pooling, clears MaaT for phase 3

Apr 24, 2023 6:10am
River in Lyon

MaaT links microbiome drug to GvHD responses, plans phase 3

Mar 17, 2021 9:30am
Research

Seres plots ulcerative colitis trial drive after posting 1b data

Oct 2, 2017 9:35am